Business

GlaxoSmithKline India appoints Sridhar Venkatesh as MD and Vice-President

From our online archive

NEW DELHI: Drug firm GlaxoSmithKline Pharmaceuticals on Tuesday said it has appointed Sridhar Venkatesh as managing director & vice president of GSK India, effective April 1, 2020.

He will succeed Annaswamy Vaidheesh, who is set to retire from the company effective March 31, 2020, GlaxoSmithKline Pharmaceuticals said in a statement.

It added that Venkatesh has more than 24 years of diverse experience in pharmaceuticals and healthcare, and has a strong track record of success in multiple roles within GSK. The statement said that he is a registered pharmacist with a master's in pharmacy.

"I warmly welcome Sridhar to lead GSK in our next phase of growth to serve the patients of India. I would also like to take this opportunity to thank Vaidheesh for his leadership during the last 5 years," GlaxoSmithKline Pharmaceuticals Chairperson Renu Karnad said.

Shares of GlaxoSmithKline Pharmaceuticals were trading at Rs 1,316.95 per scrip on the BSE, up 1.26 per cent from its previous close.

SCROLL FOR NEXT